The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 Outbreak.

ABSTRACT: The coronavirus disease 19 (COVID-19) pandemic poses a serious threat to the sustainability of healthcare systems and is currently having a significant effect on living conditions worldwide. No therapeutic agent has yet proven to be effective for the treatment of COVID-19. The management of this disease currently relies on supportive care and the off-label and compassionate use of antivirals and immunomodulators. Nevertheless, there has been a great worldwide effort to progress research and test the efficacy and safety/tolerability profiles of numerous candidate agents that may positively affect the various clinical syndromes associated with COVID-19. In parallel, vaccination and chemoprophylaxis strategies are being investigated. This article provides a summary of interventional studies t

SUBMITTER: Canevelli M 

PROVIDER: S-EPMC7542224 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature